Your browser doesn't support javascript.
loading
BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.
Than, Hein; Lye, Weng K; Sng, Colin; Allen, John C; Ong, S Tiong; Chuah, Charles.
  • Than H; a Department of Hematology , Singapore General Hospital , Singapore , Singapore.
  • Lye WK; b Centre for Quantitative Medicine , Duke-NUS Medical School Singapore , Singapore , Singapore.
  • Sng C; a Department of Hematology , Singapore General Hospital , Singapore , Singapore.
  • Allen JC; b Centre for Quantitative Medicine , Duke-NUS Medical School Singapore , Singapore , Singapore.
  • Ong ST; a Department of Hematology , Singapore General Hospital , Singapore , Singapore.
  • Chuah C; c Program for Cancer and Stem Cell Biology , Duke-NUS Medical School Singapore , Singapore , Singapore.
Leuk Lymphoma ; 60(1): 234-237, 2019 01.
Article en En | MEDLINE | ID: mdl-29916288

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Biomarcadores de Tumor / Mesilato de Imatinib / Proteína 11 Similar a Bcl2 / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Biomarcadores de Tumor / Mesilato de Imatinib / Proteína 11 Similar a Bcl2 / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article